Germline TP53 mutations predispose individuals to multiple cancers and are associated with Li-Fraumeni/Li-Fraumeni-Like Syndromes (LFS/LFL). The founder mutation TP53 p.R337H is detected in 0.3% of the general population in southern Brazil. This mutation is associated with an increased risk of childhood adrenal cortical carcinoma (ACC) but is also common in Brazilian LFS/LFL families. Breast Cancer (BC) is one of the most common cancers diagnosed in TP53 mutation carriers. We have assessed the prevalence of p.R337H in two groups: (1) 59 BC affected women with a familial history (FH) suggestive of hereditary cancer syndrome but no LFS/LFL features; (2) 815 BC affected women unselected for cancer FH, diagnosed with BC at or before age 45 or at age 55 or older. Among group 1 and group 2 patients, 2/59 (3.4%, CI95%: 0.4%–11.7%) and 70/815 (8.6%, CI95%: 6.8%–10.7%), respectively, were p.R337H carriers in the germline. The prevalence of p.R337H was higher in women diagnosed with BC at or before age 45 (12.1%, CI95%: 9.1%–15.8%) than at age 55 or older (5.1%, CI95%: 3.2%–7.7%), p<0.001). The Brazilian founder p.R337H haplotype was detected in all carriers analysed. These results suggest that inheritance of p.R337H may significantly contribute to the high incidence of BC in Brazil, in addition to its recently demonstrated impact on the risk of childhood ACC.

BACKGROUND: Pediatric cancers are a feature in patients with Li‐Fraumeni syndrome and its variant Li‐Fraumeni–like syndrome (LFS/LFL). To the best of the authors' knowledge, TP53 germline mutations are currently the only molecular defect known to be associated with this disease. Recently, a specific germline mutation in this gene, p.R337H, has been reported at a high prevalence in Brazil.METHODS: The prevalence of LFS/LFL was investigated in children with cancer who were diagnosed with tumors on the LFS/LFL spectrum and in a small consecutive series of controls without cancer. The prevalence of the germline p.R337H mutation and of other germline TP53 mutations was investigated in a general group of children with cancer and exclusively in children fulfilling the clinical criteria for LFS/LFL, respectively.RESULTS: Among the 65 children without cancer, 1.5% had a family history of LFL whereas of the 292 children with cancer, 25.3% had a family history of LFL (P < .001). Screening for the p.R337H mutation identified 11 carriers (3.7%), 9 of whom were diagnosed with adrenocortical carcinomas (ACC) and 2 of whom were diagnosed with choroid plexus carcinomas. One of the ACC probands was homozygous mutant. The Brazilian founder haplotype and loss of heterozygosity at the p.R337H locus were present in all carriers. In addition, direct sequencing of the entire TP53 coding region and gene rearrangement analysis of probands fulfilling the criteria for LFL (Eeles 2 criteria, Birch and/or Chompret criteria) and who were negative for the p.R337H mutation revealed a DNA‐binding domain pathogenic mutation, p.G245S, in 1 child.CONCLUSIONS: TP53 p.R337H testing should be offered to Brazilian children diagnosed with ACC and choroid plexus carcinoma. A significant percentage of children with cancer in southern Brazil fulfill the criteria for LFL and should be referred for genetic risk assessment. Cancer 2013;119:4341–4349. © 2013 American Cancer Society.

Personal health records (PHR) represent health data managed by a specific individual. Traditional solutions rely on centralized architectures to store and distribute PHR, which are more vulnerable to security breaches. To address such problems, distributed network technologies, including blockchain and distributed hash tables (DHT) are used for processing, storing, and sharing health records. Furthermore, fully homomorphic encryption (FHE) is a set of techniques that allows the calculation of encrypted data, which can help to protect personal privacy in data sharing. In this context, we propose an architectural model that applies a DHT technique called the interplanetary protocol file system and blockchain networks to store and distribute data and metadata separately; two new elements, called data steward and shared data vault, are introduced in this regard. These new modules are responsible for segregating responsibilities from health institutions and promoting end-to-end encryption; therefore, a person can manage data encryption and requests for data sharing in addition to restricting access to data for a predefined period. In addition to supporting calculations on encrypted data, our contribution can be summarized as follows: (i) mitigation of risk to personal privacy by reducing the use of unencrypted data, and (ii) improvement of semantic interoperability among health institutions by using distributed networks for standardized PHR. We evaluated performance and storage occupation using a database with 1.3 million COVID-19 registries, which showed that combining FHE with distributed networks could redefine e-health paradigms.

There is a strong relation between chronic UV-B-induced sunburns and the development of skin cancer. Therefore, it is important to obtain a method that can be reproduced easily to detect individuals with similar skin color but different sensitiveness to sun exposure. The study evaluated 193 healthy volunteers (68% women; the average age was 38 years). They were divided into six groups of at least 30 subjects, according to skin type. The minimal erythema dose (MED) was assessed in two non-sun-exposed areas (thorax-infra-axillary area and on the buttocks), using a UV-B source (0.5 mW/cm2), with openings of 1 cm2, in increasing doses. The same areas were evaluated with a Minolta CR 300 Chromameter (L*a*b* system). The MED values ranged from 13 to 156 mJ/cm2; the coordinate L* (brightness) ranged from 75.96 to 30.15. The correlation between the MED and the brightness was negative in both areas (Pearson's correlation r = -0.91, P < 0.05). Color measurements, especially brightness, can be used to quickly assess skin sensibility. Considering the MED, there is a substantial overlapping of adjacent phototypes, but they could be separated into two groups: more sensitive individuals (Types I, II, III and IV) and less sensitive ones (Types V and VI).

OBJETIVO: Avaliar o processo de tomada de decisão e a qualidade de vida de pacientes adultos, oncológicos, internados em unidade de cuidados paliativos. MÉTODOS: Estudo transversal, realizado ao longo de 12 meses, incluiu 89 pacientes que aceitaram participar respondendo aos instrumentos de Desenvolvimento Psicológico-Moral, WHOQOL-OLD e WHOQOL-BREF. RESULTADOS: Na avaliação do Desenvolvimento Psicológico-Moral, os pacientes demonstraram ter capacidade para tomar decisões em seu melhor interesse. Nos domínios do WHOQOL-OLD, a Participação social teve a menor média, e a Intimidade, a melhor. Na aplicação do instrumento WHOQOL-BREF, o domínio Físico teve a menor média, sendo o Meio Ambiente o de melhor desempenho. CONCLUSÃO: Os pacientes demonstraram-se satisfeitos com a capacidade de estabelecer relações sociais, pessoais e íntimas, mesmo estando internados.